Literature DB >> 34390380

Intracranial thrombosis after ventriculoperitoneal shunting.

Nayara M Pereira1, Luiz A Vieira Netto2, Luís Felipe A Peres2, Alice J Zaccariotti2, Lígia G Ribeiro3, Paulo Ronaldo Jubé Ribeiro2.   

Abstract

We report a case of intracranial thrombosis (IT) after ventriculoperitoneal shunting (VPS). We reviewed the literature to highlight the importance of considering the possibility of cerebral venous thrombosis following VPS, even though it is a rarely reported complication. A 14-year-old boy underwent distal catheter replacement due to its short size that was detected during a routine consultation. Five days postoperatively, he experienced nausea, vomiting, seizures, and headache. Although a diagnosis of meningitis was considered, diagnosis of IT was eventually confirmed through computed tomography venography and gadolinium magnetic angioresonance. The patient subsequently underwent anticoagulant therapy, which led to complete resolution of symptoms. In this report, we suggest a possible association between VPS and IT, which is a complication that is not commonly reported. The literature suggests that decreased blood flow due to over-drainage of CSF after VPS causes decreased head pressure, culminating in venous stasis and consequent thrombosis. In addition, the literature describes associations between IT and lumbar puncture (LP); therefore, it is important to consider the possibility of IT following these procedures.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Complications; Heparin; Intracranial thrombosis; Ventriculoperitoneal shunt

Mesh:

Substances:

Year:  2021        PMID: 34390380     DOI: 10.1007/s00381-021-05319-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.532


  11 in total

Review 1.  Changing pattern of headache pointing to cerebral venous thrombosis after lumbar puncture and intravenous high-dose corticosteroids.

Authors:  S Aidi; M P Chaunu; V Biousse; M G Bousser
Journal:  Headache       Date:  1999-09       Impact factor: 5.887

2.  Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis.

Authors:  E Wilder-Smith; I Kothbauer-Margreiter; B Lämmle; M Sturzenegger; C Ozdoba; S P Hauser
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

3.  Cortical venous thrombosis after lumbar puncture.

Authors:  André Mouraux; Michel Gille; Stéphanie Dorban; André Peeters
Journal:  J Neurol       Date:  2002-09       Impact factor: 4.849

4.  Pediatric cerebral sinovenous thrombosis following cranial surgery.

Authors:  Dmitriy Petrov; Michael Y Uohara; Rebecca Ichord; Zarina Ali; Laura Jastrzab; Shih-Shan Lang; Lori Billinghurst
Journal:  Childs Nerv Syst       Date:  2017-01-14       Impact factor: 1.475

5.  Malignant Hyperthermia and Cerebral Venous Sinus Thrombosis After Ventriculoperitoneal Shunt in Infant with Schizencephaly and COL4A1 Mutation.

Authors:  Jun Watanabe; Kouichirou Okamoto; Tsukasa Ohashi; Manabu Natsumeda; Hitoshi Hasegawa; Makoto Oishi; Satoko Miyatake; Naomichi Matsumoto; Yukihiko Fujii
Journal:  World Neurosurg       Date:  2019-04-25       Impact factor: 2.104

6.  Tumefaction of the dural sinuses associated with a coagulopathy following treatment of hydrocephalus in a perinate: case report.

Authors:  William C Hanigan; Ken Fraser; Michael Tarantino; Huan Wang
Journal:  J Neurosurg       Date:  2005-05       Impact factor: 5.115

7.  Cerebral venous thrombosis complicated by hemorrhagic infarction secondary to ventriculoperitoneal shunting.

Authors:  Won-Soo Son; Jaechan Park
Journal:  J Korean Neurosurg Soc       Date:  2010-10-30

Review 8.  Infantile hydrocephalus: a review of epidemiology, classification and causes.

Authors:  Hannah M Tully; William B Dobyns
Journal:  Eur J Med Genet       Date:  2014-06-13       Impact factor: 2.708

Review 9.  Hydrocephalus in children.

Authors:  Kristopher T Kahle; Abhaya V Kulkarni; David D Limbrick; Benjamin C Warf
Journal:  Lancet       Date:  2015-08-06       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.